(Q38109957)

29 August 2017

The assessment of vascular risk in men with erectile dysfunction: the role of the cardiologist and general physician (English)

1 reference

29 August 2017

1 reference

G Jackson

1

1 reference

29 August 2017

A Nehra

2

1 reference

29 August 2017

M Miner

3

1 reference

29 August 2017

K L Billups

4

1 reference

29 August 2017

A L Burnett

5

1 reference

29 August 2017

J Buvat

6

1 reference

29 August 2017

C C Carson

7

1 reference

29 August 2017

G Cunningham

8

1 reference

29 August 2017

I Goldstein

9

1 reference

29 August 2017

A T Guay

10

1 reference

29 August 2017

G Hackett

11

1 reference

29 August 2017

R A Kloner

12

1 reference

29 August 2017

J B Kostis

13

1 reference

29 August 2017

P Montorsi

14

1 reference

29 August 2017

M Ramsey

15

1 reference

29 August 2017

R Rosen

16

1 reference

29 August 2017

R Sadovsky

17

1 reference

29 August 2017

A D Seftel

18

1 reference

29 August 2017

R Shabsigh

19

1 reference

29 August 2017

C Vlachopoulos

20

1 reference

29 August 2017

F C W Wu

21

1 reference

29 August 2017

28 May 2013

1 reference

International Journal of Clinical Practice

29 August 2017

1 reference

29 August 2017

67

1 reference

29 August 2017

11

1 reference

29 August 2017

1163-1172

1 reference

Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation

29 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Prevention of cardiovascular disease by the early identification of erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Androgens and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Endogenous testosterone and cardiovascular disease in healthy men: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Endocrine aspects of male sexual dysfunctions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Functions of the healthy endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Testing endothelial vasomotor function: nitric oxide, a multipotent molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Endothelial dysfunction links erectile dysfunction to heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Persistent impairment of endothelial vasomotor function has a negative impact on outcome in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Vascular aetiology of erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Association between erectile dysfunction and coronary artery disease: Matching the right target with the right test in the right patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Penile doppler ultrasound in patients with erectile dysfunction (ED): role of peak systolic velocity measured in the flaccid state in predicting arteriogenic ED and silent coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Erectile and endothelial dysfunction in Type II diabetes: a possible link

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

The triad: erectile dysfunction--endothelial dysfunction--cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE i

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Does erectile dysfunction contribute to cardiovascular disease risk prediction beyond the Framingham risk score?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Erectile dysfunction and later cardiovascular disease in men with type 2 diabetes: prospective cohort study based on the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation) trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Should erectile dysfunction be considered as a marker for acute myocardial infarction? Results from a retrospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Is erectile dysfunction an indicator for increased risk of coronary heart disease and stroke?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Erectile dysfunction severity as a risk predictor for coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

The association between erectile dysfunction and peripheral arterial disease as determined by screening ankle-brachial index testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

The artery size hypothesis: a macrovascular link between erectile dysfunction and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Erectile dysfunction and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

A population-based, longitudinal study of erectile dysfunction and future coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Erectile dysfunction as a predictor for subsequent atherosclerotic cardiovascular events: findings from a linked-data study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Erectile dysfunction and coronary artery disease: an association of higher risk in younger men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

The temporal relationship between erectile dysfunction and cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Endothelial regulation of eNOS, PAI-1 and t-PA by testosterone and dihydrotestosterone in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Testosterone regulates PDE5 expression and in vivo responsiveness to tadalafil in rat corpus cavernosum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Characterization of patients in a medical endocrine-based center for male sexual dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Significance of hypogonadism in erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Clinical review: Endogenous testosterone and mortality in men: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Low testosterone levels are common and associated with insulin resistance in men with diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Sex hormones, inflammation and the metabolic syndrome: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Low testosterone in men with type 2 diabetes: significance and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Testosterone treatment and mortality in men with low testosterone levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Prediction of cardiovascular events and all-cause mortality with erectile dysfunction: a systematic review and meta-analysis of cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Erectile dysfunction is associated with a high prevalence of hyperlipidemia and coronary heart disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Sexual activity in hypertensive men treated with valsartan or carvedilol: a crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Effect of irbesartan on erectile function in patients with hypertension and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Effect of correcting serum cholesterol levels on erectile function in patients with vasculogenic erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Improvement in erectile function in men with organic erectile dysfunction by correction of elevated cholesterol levels: a clinical observation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Low serum testosterone and mortality in male veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Low serum testosterone and mortality in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Low serum testosterone levels are associated with increased risk of mortality in a population-based cohort of men aged 20-79.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Low serum testosterone and increased mortality in men with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Low serum testosterone and estradiol predict mortality in elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Sex steroid hormone concentrations and risk of death in US men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Endogenous sex hormones and the prospective association with cardiovascular disease and mortality in men: the Tromsø Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Low testosterone is associated with an increased risk of MACE lethality in subjects with erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Coronary Calcium as a Predictor of Coronary Events in Four Racial or Ethnic Groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

The detection of any coronary calcium outperforms Framingham risk score as a first step in screening for coronary atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Erectile dysfunction and silent coronary artery disease: abnormal computed tomography coronary angiogram in the presence of normal exercise ECGs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Arterial function and intima-media thickness in hypertensive patients with erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

Independent determinants of coronary artery disease in erectile dysfunction patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12200

21 January 2018

Identifiers

DOI

10.1111/IJCP.12200

1 reference

29 August 2017

1 reference